VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 183 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21 | 0.0% | 3,142 | 0.0% | 0.00% | – |
| Q2 2023 | $21 | 0.0% | 3,142 | 0.0% | 0.00% | – |
| Q1 2023 | $21 | -61.1% | 3,142 | -42.7% | 0.00% | – |
| Q4 2022 | $54 | -99.9% | 5,483 | 0.0% | 0.00% | – |
| Q3 2022 | $54,000 | -10.0% | 5,483 | 0.0% | 0.00% | – |
| Q2 2022 | $60,000 | -51.2% | 5,483 | -49.6% | 0.00% | – |
| Q1 2022 | $123,000 | -62.7% | 10,872 | -48.4% | 0.00% | -100.0% |
| Q4 2021 | $330,000 | -8.6% | 21,060 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $361,000 | -60.2% | 21,060 | -50.0% | 0.00% | -50.0% |
| Q2 2021 | $906,000 | +43.4% | 42,120 | 0.0% | 0.00% | +100.0% |
| Q1 2021 | $632,000 | -43.4% | 42,120 | +172.6% | 0.00% | – |
| Q4 2020 | $1,117,000 | +644.7% | 15,452 | 0.0% | 0.00% | – |
| Q3 2020 | $150,000 | -14.8% | 15,452 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $176,000 | – | 15,452 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
| Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
| Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
| Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
| EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
| Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
| EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
| ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
| 361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |